Antineoplastics and Immunomodulating Agents

Ruxolitinib is used for the treatment of symptoms in adult patients with primary myelofibrosis which is a rare form of blood cancer. Ruxolitinib comes in four strengths, 5 mg, 10 mg, 15 mg and 20 mg. Pivotal BE study is completed and passing and we expect to have the dossier available in Q1 2024.

Bosutinib is used to treat chronic myeloid leukaemia (CML), a cancer of the white blood cells, in adults with a special chromosome in their cells called the Philadelphia chromosome.Bosutinib is available in three strengths, 100, 400 and 500mg, all three strengths are being developed here in our R&...

Albumin bound Paclitaxel Inj Azacitadine Inj Bendamustin Inj Bortezomib Inj Busulfan Inj Carboplatin Inj Carfilzomib Inj Carmustin Inj Cisplatin Inj Cytrabine Inj Dacarbazine Inj Dactinomycin Inj Degrarelix Inj Doceteaxel Inj Doxorubicin Inj Epirubicin Inj Eribulin Inj Etoposide Inj Fludarabine Inj Fosapre...

Tablets 1 Zefinib Gefitinib 250mg 1 x 10 2 Capetaz Capecetabine 500mg 1 x 10 3 Anastroz Anastrozole 1mg 1 x 10 4 Zutam Tamoxifen 20mg 1 x 10 5 Zuvitrex Methotrexate 2.5mg 1 x 10 6 Zuvitrex Methotrexate 7.5mg 1 x 10 7 Erlonon Erlotinib 100mg 1 x 10 8 Erlonon Erlotinib 150mg 1 x 10 9 Zuvitroz Letrozole ...

Cytopharma is the first pharmaceutical company in Africa & Middle East region entirely specialized in the development, manufacturing and marketing of high quality and affordable generic cytotoxic drugs. Established in Tunisia since 2011, Cytopharma purpose is to provide high quality and affordable...